Characterization, stability and solubility of co-amorphous systems of glibenclamide and L-arginine at different pH

被引:0
|
作者
Aragon-Aburto, Salma O. [1 ,2 ]
Mondragon-Vasquez, Karina [1 ]
Valerio-Alfaro, Gerardo [2 ]
Dominguez-Chavez, Jorge G. [1 ]
机构
[1] Univ Veracruzana, Fac Bioanal Reg Veracruz, Agustin De Iturbide 91700, Mexico
[2] Tecnol Nacl Mexico IT Veracruz, UNIDA, Miguel A de Quevedo 2779, Veracruz 91860, Mexico
关键词
Co-amorphous; Glibenclamide; L-Arginine; Solubility; Stability; AMINO-ACIDS; DISSOLUTION; BIOAVAILABILITY; STABILIZATION; PROTEIN; DRUGS;
D O I
10.4314/tjpr.v21i7.1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To investigate the stability and solubility of co-amorphous systems of glibenclamide (GBC) with L-arginine (L-Arg) at different pH values. Methods: Three co-amorphous solids of GBC and L-Arg were obtained by fast solvent evaporation using 2:1, 1:1 and 1:2 stoichiometries. All co-amorphous systems were characterized by XRPD, FTIR, RAMAN and NMR-solid state as well as thermal techniques such as DSC and TGA. The stability of co-amorphous systems was evaluated by indicative stability and stability in relevant physiological media was measured at different pH values. Results: The chemical characterization suggest that there was no proton transference between L-Arg and GBC indicative of co-amorphous solids. Stability studies showed that all the co-amorphous solids are unstable under humid conditions and only the co-amorphous system of GBC: L-Arg 1:2 was stable in all the pH values tested. Solubility studies at different pH values showed that the co-amorphous GBC: L-Arg 1:1 and 1:2, showed increasing solubility values even at pH < 7 (0.6468 mg/mL at pH 1.2 for co-amorphous GBC: L-Arg 1:2 at the first hour) where free GBC was not soluble. Conclusion: Co-amorphous systems of GBC and L-Arg, is an interesting strategy to increase the solubility of poorly-soluble drugs at acidic pH values
引用
收藏
页码:1355 / 1364
页数:10
相关论文
共 50 条
  • [1] Development of a Novel Co-Amorphous Curcumin and L-Arginine (1:2): Structural Characterization, Biological Activity and Pharmacokinetics
    Mancillas-Quiroz, Jose Antonio
    Carrasco-Portugal, Miriam del Carmen
    Mondragon-Vasquez, Karina
    Huerta-Cruz, Juan Carlos
    Rodriguez-Silverio, Juan
    Rodriguez-Vera, Leyanis
    Reyes-Garcia, Juan Gerardo
    Flores-Murrieta, Francisco Javier
    Dominguez-Chavez, Jorge Guillermo
    Rocha-Gonzalez, Hector Isaac
    PHARMACEUTICS, 2025, 17 (01)
  • [2] Co-formability, solubility enhancement and stability of olanzapine co-amorphous systems produced with different co-formers
    Bastos, Ana C.
    Santos, Ines A.
    Pinto, Joao F.
    Fernandes, Ana I.
    ANNALS OF MEDICINE, 2021, 53 : S112 - S113
  • [3] Amino Acids as Co-amorphous Excipients for Simvastatin and Glibenclamide: Physical Properties and Stability
    Laitinen, Riikka
    Lobmann, Korbinian
    Grohganz, Holger
    Strachan, Clare
    Rades, Thomas
    MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 2381 - 2389
  • [4] Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems
    Wu, Wenqi
    Wang, Yixuan
    Lobmann, Korbinian
    Grohganz, Holger
    Rades, Thomas
    MOLECULAR PHARMACEUTICS, 2019, 16 (03) : 1294 - 1304
  • [5] Norfloxacin co-amorphous salt systems: Effects of molecular descriptors on the formation and physical stability of co-amorphous systems
    Deng, Yuehua
    Deng, Wenhao
    Huang, Wenquan
    Zheng, Zhiyong
    Zhang, Rui
    Liu, Shiyuan
    Jiang, Yanbin
    CHEMICAL ENGINEERING SCIENCE, 2022, 253
  • [6] The influence of moisture on the storage stability of co-amorphous systems
    Liu, Jingwen
    Rades, Thomas
    Grohganz, Holger
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 605
  • [7] Tannic acid as a co-former in co-amorphous systems: Enhancing their physical stability, solubility and dissolution behavior
    Fael, Hanan
    Demirel, A. Levent
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 581
  • [8] Preparation and Characterization of Lutein Co-Amorphous Formulation with Enhanced Solubility and Dissolution
    Song, Xuening
    Luo, Yingting
    Zhao, Wenduo
    Liu, Simiao
    Wang, Yuzhuo
    Zhang, Hao
    FOODS, 2024, 13 (13)
  • [9] Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods
    Park, Heejun
    Seo, Hye Jin
    Hong, Seung-hyeon
    Ha, Eun-Sol
    Lee, Sibeum
    Kim, Jeong-Soo
    Baek, In-hwan
    Kim, Min-Soo
    Hwang, Sung-Joo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 581
  • [10] Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability
    Liu, Xianzhi
    Shen, Luyan
    Zhou, Lin
    Wu, Wencheng
    Liang, Guang
    Zhao, Yunjie
    Wu, Wenqi
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 200